Annual EBITDA
$1.56B$270.93M+20.96%
Summary
- Current Value
- As of today, RPRX annual EBITDA is $1.56B, up +20.96% on
- Historical Performance
- RPRX annual EBITDA is up +68.36% over the past 3 years, down -3.40% over the past 5 years
- All-Time High Comparison
- RPRX annual EBITDA is currently -40.94% below its historical high of $2.65B set on
- 3-Year Low Comparison
- RPRX annual EBITDA is +68.36% above its 3-year low of $928.56M reached on an earlier date
- Sector Comparison
- RPRX annual EBITDA is higher than 94.70% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.56B | +21.0% | +68.4% | -3.4% | +81.3% | |
| Quarterly EBITDA | $389.20M | +7.8% | +192.6% | +21.6% | -11.0% | |
| TTM EBITDA | $1.56B | +20.9% | +68.2% | -3.5% | +256.9% | |
| Price | $45.68 | +35.3% | +28.2% | +7.4% | – | |
| PE Ratio | 25.65 | +45.7% | -91.9% | +58.5% | – | |
| Annual Revenue | $2.38B | +5.1% | +6.3% | +12.1% | +43.9% | |
| Annual EPS | $1.78 | -6.8% | +1721.5% | -31.4% | +86.0% | |
| $1.56B | +20.7% | +69.0% | -2.3% | +96.3% | ||
| Annual Net Income | $1.32B | -0.5% | +475.6% | -22.2% | +74.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.56B | at high | |
| 5Y | $1.62B | N/A | -3.4% |
| All | $2.65B | -40.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $928.56M | N/A | +68.4% |
| 5Y | $928.56M | +68.4% | |
| All | $791.08M | +97.6% |
EBITDA History
FAQ
What is the current annual EBITDA of RPRX?
As of today, RPRX annual EBITDA is $1.56B
What is 1-year change in RPRX annual EBITDA?
RPRX annual EBITDA is up +20.96% year-over-year
What is 3-year change in RPRX annual EBITDA?
RPRX annual EBITDA is up +68.36% over the past 3 years
How far is RPRX annual EBITDA from its all-time high?
RPRX annual EBITDA is currently -40.94% below its historical high of $2.65B set on December 31, 2019
How does RPRX annual EBITDA rank versus sector peers?
RPRX annual EBITDA is higher than 94.70% of companies in Healthcare sector
When is RPRX next annual earnings release?
As of today, the next annual earnings release for RPRX has not been scheduled
Quarterly EBITDA
$389.20M$39.24M-9.16%
Summary
- Current Value
- As of today, RPRX quarterly EBITDA is $389.20M, down -9.16% on
- Historical Performance
- RPRX quarterly EBITDA is up +7.81% year-over-year, up +192.63% over the past 3 years
- All-Time High Comparison
- RPRX quarterly EBITDA is currently -70.91% below its historical high of $1.34B set on
- 3-Year Low Comparison
- RPRX quarterly EBITDA is +627.55% above its 3-year low of -$73.77M reached on
- Sector Comparison
- RPRX quarterly EBITDA is higher than 94.70% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $389.20M | -9.2% | +7.8% | +192.6% | +21.6% | |
| Annual EBITDA | $1.56B | – | +21.0% | +68.4% | -3.4% | |
| TTM EBITDA | $1.56B | +1.8% | +20.9% | +68.2% | -3.5% | |
| Price | $45.68 | +15.0% | +35.3% | +28.2% | +7.4% | |
| PE Ratio | 25.65 | +12.9% | +45.7% | -91.9% | +58.5% | |
| Quarterly Revenue | $622.00M | +2.1% | +4.7% | +9.9% | +8.7% | |
| Quarterly EPS | $0.50 | -25.0% | +6.8% | +148.5% | +13.3% | |
| $388.00M | -9.2% | +7.5% | +191.7% | +23.6% | ||
| Quarterly Net Income | $356.00M | -19.9% | +6.6% | +158.4% | -3.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $534.18M | -27.1% | |
| 3Y | $735.07M | -47.0% | |
| 5Y | $750.68M | -48.1% | |
| All | $1.34B | -70.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $209.80M | +85.5% | |
| 3Y | -$73.77M | +627.5% | |
| 5Y | -$73.77M | +627.5% | |
| All | -$73.77M | +627.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RPRX?
As of today, RPRX quarterly EBITDA is $389.20M
What is RPRX quarterly EBITDA most recent change?
RPRX quarterly EBITDA was down -9.16% on December 31, 2025
What is 1-year change in RPRX quarterly EBITDA?
RPRX quarterly EBITDA is up +7.81% year-over-year
How far is RPRX quarterly EBITDA from its all-time high?
RPRX quarterly EBITDA is currently -70.91% below its historical high of $1.34B set on December 31, 2019
How does RPRX quarterly EBITDA rank versus sector peers?
RPRX quarterly EBITDA is higher than 94.70% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
TTM EBITDA
$1.56B$28.20M+1.84%
Summary
- Current Value
- As of today, RPRX TTM EBITDA is $1.56B, up +1.84% on
- Historical Performance
- RPRX TTM EBITDA is up +20.87% year-over-year, up +68.21% over the past 3 years
- All-Time High Comparison
- RPRX TTM EBITDA is currently -41.25% below its historical high of $2.66B set on
- 3-Year Low Comparison
- RPRX TTM EBITDA is +68.21% above its 3-year low of $928.39M reached on an earlier date
- Sector Comparison
- RPRX TTM EBITDA is higher than 94.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.56B | +1.8% | +20.9% | +68.2% | -3.5% | |
| Annual EBITDA | $1.56B | – | +21.0% | +68.4% | -3.4% | |
| Quarterly EBITDA | $389.20M | -9.2% | +7.8% | +192.6% | +21.6% | |
| Price | $45.68 | +15.0% | +35.3% | +28.2% | +7.4% | |
| PE Ratio | 25.65 | +12.9% | +45.7% | -91.9% | +58.5% | |
| TTM Revenue | $2.38B | +1.2% | +5.0% | +6.3% | +12.1% | |
| TTM EPS | $1.78 | +1.8% | -7.1% | +1477.2% | -32.3% | |
| $1.56B | +1.8% | +20.7% | +69.0% | -2.3% | ||
| TTM Net Income | $1.32B | +1.7% | -0.5% | +475.5% | -22.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.90B | -17.8% | |
| 3Y | $1.90B | -17.8% | |
| 5Y | $1.90B | -17.8% | |
| All | $2.66B | -41.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.29B | N/A | +20.9% |
| 3Y | $928.39M | N/A | +68.2% |
| 5Y | $928.39M | +68.2% | |
| All | $437.50M | +256.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RPRX?
As of today, RPRX TTM EBITDA is $1.56B
What is RPRX TTM EBITDA most recent change?
RPRX TTM EBITDA was up +1.84% on December 31, 2025
What is 1-year change in RPRX TTM EBITDA?
RPRX TTM EBITDA is up +20.87% year-over-year
How far is RPRX TTM EBITDA from its all-time high?
RPRX TTM EBITDA is currently -41.25% below its historical high of $2.66B set on June 30, 2020
How does RPRX TTM EBITDA rank versus sector peers?
RPRX TTM EBITDA is higher than 94.79% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276826000003/0001802768-26-000003-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276826000003/0001802768-26-000003-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx